2022 Sponsors & Exhibitors

Orphan Drugs & Rare Diseases - West Coast, USA

Gold Sponsor

Orphan

Smartway designs, implements and manages global programs that empower access to innovative therapies.

We partner with pharma and biotech organizations to deliver customized programs that transform lives. These partnerships have made us a leader in the provision of Expanded Access, Early Access, Compassionate Use and Named Patient Programs across 98 countries. Over the last 20 years, we’ve gained the experience it takes to strategically advice, design, initiate and manage global or regional programs with you.

We provide end-to-end solutions to manage complex EAPs. Whatever your size and scale, we’re dedicated to empowering patient access to the right therapy

www.smartwaypharma.com

Visit Website

Gold Sponsor

Orphan

Established over 50 years ago, Durbin is one of the world’s leading specialist Expanded Access Program providers, offering a bespoke distribution platform to provide patients with access to unlicensed and speciality medicines in over 160 countries. With offices and warehousing in the UK, Europe, and USA, Durbin takes a strategic, consultative approach to understand the precise needs of the pharmaceutical company, the product, the disease area, and of the HCPs and patients in question. We then draw on technology to design a 360° solution that incorporates effective global distribution, country-specific regulations, and real-world data insights.

Visit https://www.durbinglobal.com//

Visit Website

Silver Sponsor

Orphan

Pulse Infoframe Inc (Pulse) believes that collaboration cures disease and Pulse enables such collaboration. A new style of healthcare informatics company, Pulse builds and supports global, healthcare ecosystems. It’s solution, healthie™, empowers consortia of pharmaceutical and medical device companies, researchers, clinicians, advocacy groups and patients, by aggregating information from a variety of sources and then, delivering key healthcare insights – real time -- derived from these data. For patients with rare diseases, Pulse’s global coverage is critical. Already great strides have been made in characterizing rare diseases using Pulse’s global and national registries. These insights help professionals to advance medical research, focus clinical trial recruitment, assist advocacy groups in their dealings with policy makers and provide real-world evidence.

Visit Website

Exhibitor

Orphan

Adaptic Health is on mission to accelerate treatments for rare diseases by helping researchers design better clinical trials through simulation and collaboration. Adaptic's platform stress-tests trial designs so clinical leaders can make better decisions throughout the clinical development program. The company was founded by AI and real world data leaders from Roche, Genentech, Pfizer and Saama Technologies.

Visit Website

To Sponsor/Exhibit

To Speak

To Register

sponsor@paradigmglobalevents.com
Tel. +44 203 567 1321

jocelynr@paradigmglobalevents.com
Tel. +44 203 567 1321

booking@paradigmglobalevents.com
Tel. +44 203 567 1321